NetraMark Holdings Inc. (AINMF)

OTCMKTS · Delayed Price · Currency is USD
1.030
0.00 (0.00%)
Jun 17, 2025, 4:00 PM EDT
381.08%
Market Cap 82.59M
Revenue (ttm) 431.60K
Net Income (ttm) -2.84M
Shares Out n/a
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 657
Open 1.030
Previous Close 1.030
Day's Range 1.030 - 1.030
52-Week Range 0.114 - 1.250
Beta 1.81
RSI 56.65
Earnings Date Aug 12, 2025

About NetraMark Holdings

NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. The company’s product suite comprises Netra Shatter; Netra Health Atlas; and NetraAi that is designed to help interact and explore with different perspective of the data for clinical trials. It provides NetraPlacebo module that analyzes past trial data to determine what drives placebo responses to guide inclusion/exclusion criteria; and Netra GPT module that offers insights from past clinical trials about the patien... [Read more]

Sector Healthcare
Founded 2016
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol AINMF
Full Company Profile

Financial Performance

In 2024, NetraMark Holdings's revenue was 456,127, an increase of 410.97% compared to the previous year's 89,267. Losses were -3.33 million, -76.49% less than in 2023.

Financial numbers in CAD Financial Statements

News

NETRAMARK TO HOST SHAREHOLDER CONFERENCE CALL TO DISCUSS BUSINESS MOMENTUM

TORONTO , April 10, 2025 /PRNewswire/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a premier artificial intelligence (AI) company that is transf...

2 months ago - PRNewsWire

NETRAMARK AND WORLDWIDE CLINICAL TRIALS ANNOUNCE AGREEMENT TO TRANSFORM CLINICAL TRIAL DESIGN WITH AI-POWERED PRECISION

TORONTO , April 3, 2025 /PRNewswire/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transfo...

2 months ago - PRNewsWire

Netramark to Present at the 2024 Cantech Letter Conference in Toronto, ON

Toronto, Ontario--(Newsfile Corp. - October 2, 2024) - NetraMark Holdings Inc. (CSE: AIAI) (OTCQB: AINMF) (FSE: 8TV) (the "Company" or "NetraMark") a generative AI software leader in clinical trial an...

9 months ago - Newsfile Corp

NETRAMARK, THE FIRST PUBLIC AI COMPANY TO LAUNCH CLINICAL TRIAL DE-RISKING TECHNOLOGY THAT INTEGRATES CHATGPT

TORONTO , May 16, 2023 /PRNewswire/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (Frankfurt: 8TV) (OTC: AINMF) announces the release of NetraGPT. Through newly developed algori...

2 years ago - PRNewsWire